title: Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
authors.affiliation: St Vincent's University Hospital, Dublin, Ireland mhutchin2@mac.com.
authors.forename: Michael
authors.initials: M
authors.lastname: Hutchinson
mesh_terms: D006801:Humans; D016899:Interferon-beta; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting; D012008:Recurrence
chemical_list: D016899:Interferon-beta